Unknown

Dataset Information

0

An in silico model of cytotoxic T-lymphocyte activation in the lymph node following short peptide vaccination.


ABSTRACT: Tumour immunotherapy is dependent upon activation and expansion of tumour-targetting immune cells, known as cytotoxic T-lymphocytes (CTLs). Cancer vaccines developed in the past have had limited success and the mechanisms resulting in failure are not well characterized. To elucidate these mechanisms, we developed a human-parametrized, in silico, agent-based model of vaccination-driven CTL activation within a clinical short-peptide vaccination context. The simulations predict a sharp transition in the probability of CTL activation, which occurs with variation in the separation rate (or off-rate) of tumour-specific immune response-inducing peptides (cognate antigen) from the major histocompatibility class I (MHC-I) receptors of dendritic cells (DCs) originally at the vaccination site. For peptides with MHC-I off-rates beyond this transition, it is predicted that no vaccination strategy will lead to successful expansion of CTLs. For slower off-rates, below the transition, the probability of CTL activation becomes sensitive to the numbers of DCs and T cells that interact subsequent to DC migration to the draining lymph node of the vaccination site. Thus, the off-rate is a key determinant of vaccine design.

SUBMITTER: Brown LV 

PROVIDER: S-EPMC5908537 | biostudies-literature | 2018 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

An <i>in silico</i> model of cytotoxic T-lymphocyte activation in the lymph node following short peptide vaccination.

Brown Liam V LV   Gaffney Eamonn A EA   Wagg Jonathan J   Coles Mark C MC  

Journal of the Royal Society, Interface 20180301 140


Tumour immunotherapy is dependent upon activation and expansion of tumour-targetting immune cells, known as cytotoxic T-lymphocytes (CTLs). Cancer vaccines developed in the past have had limited success and the mechanisms resulting in failure are not well characterized. To elucidate these mechanisms, we developed a human-parametrized, <i>in silico</i>, agent-based model of vaccination-driven CTL activation within a clinical short-peptide vaccination context. The simulations predict a sharp trans  ...[more]

Similar Datasets

| S-EPMC3102372 | biostudies-literature
| S-EPMC6029500 | biostudies-literature
| S-EPMC6446103 | biostudies-literature
| S-EPMC5263259 | biostudies-literature
| S-EPMC1163721 | biostudies-other
| S-EPMC1172542 | biostudies-other
| S-EPMC8744208 | biostudies-literature
| S-EPMC3670500 | biostudies-literature
| S-EPMC9616425 | biostudies-literature
| S-EPMC6124534 | biostudies-literature